Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer

Clinical trial NCT04703920 · COMPLETED

Trial details

NCT number: NCT04703920
Sponsor: University of Michigan Rogel Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Breast Cancer Metastatic Castration-resistant Prostate Cancer Metastatic Ovarian Carcinoma Metastic or Unresectable Pancreatic Adenocarcinoma

Start date: 2021-03-04
Primary completion: 2024-12-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.